Role of the renin-angiotensin system in the compensation of quinpirole-induced blood pressure decrease

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 367, Issue 5, 2003, Pages 427-433

  Luippold, Gerd ^a   Max, Alexander ^a   Albinus, Margitta ^a   Osswald, Hartmut ^a   Mühlbauer, Bernd ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Anesthetized rats; Blood pressure; Dopamine D2 like receptors; Quinpirole; Renal denervation; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN ANTAGONIST; DOPAMINE 2 RECEPTOR; LOSARTAN; QUINPIROLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG CLEARANCE; DRUG MECHANISM; HYPERTENSION; KIDNEY DENERVATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; RECEPTOR UPREGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; VASODILATATION;

ANESTHESIA; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; DENERVATION; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART RATE; HYPOTENSION; KIDNEY; KIDNEY FUNCTION TESTS; LOSARTAN; MALE; QUINPIROLE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; RENIN-ANGIOTENSIN SYSTEM;

EID: 0038459194     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-003-0740-5     Document Type: Article

References (34)

1. Albinus M, Finkbeiner E, Sosath B, Osswald H (1998) Isolated superfused juxtaglomerular cells from rat kidney: a model for study of renin secretion. Am J Physiol 275:F991-F997
2. Amenta F (1990) Density and distribution of dopamine receptors in the cardiovascular system and in the kidney. J Auton Pharmacol 10:11-18
3. 3 receptor gene produces renin-dependent hypertension. J Clin Invest 102:493-498
4. Cavero I, Thiry C, Pratz J, Lawson K (1987) Cardiovascular characterization of DA-1 and DA-2 dopamine receptor agonists in anesthetized rats. Clin Exp Hypertens A 9:931-952
5. 2 receptors. Kidney Int 67:S95-S99
6. Damase-Michel C, Montastruc JL, Gharib C, Geelen G, Saint-Blanquat G, Tran MA (1990) Effect of quinpirole, a specific dopamine DA2 receptor agonist on the sympathoadrenal system in dogs. J Pharmacol Exp Ther 252:770-777
7. Eilam D, Szechtman H (1989) Biphasic effect of the D-2 agonist quinpirole on locomotion and movements. Eur J Pharmacol 161:151-157
8. 2 agonist, LY 141865, in spontaneously hypertensive rats exhibiting biochemical and endocrine responses similar to those in nor-motensive rats. J Pharmacol Exp Ther 227:354-359
9. Hahn RA, MacDonald BR (1984) Systemic hemodynamic and regional blood flow effects of LY141865, a selective dopamine receptor agonist. J Pharmacol Exp Ther 230:558-568
10. Hahn RA, MacDonald BR, Martin MA (1983) Antihypertensive activity of LY 141865, a selective presynaptic dopamine receptor agonist. J Pharmacol Exp Ther 224:206-214
11. Igarashi Y, Chen YF, Wyss JM, Lindheimer MD, Oparil S (1987) Continuous intravenous infusion of LY171555, a potent selective D, receptor agonist, lowers blood pressure in the conscious rat. Pharmacology 35:194-202
12. Jose PA, Eisner GM, Felder RA (1998) Renal dopamine receptors in health and hypertension. Pharmacol Ther 80: 149-182
13. Kebabian JW, Calne DB (1979) Multiple receptors for dopamine. Nature 277:93-96
14. Kinoshita S, Sidhu A, Felder RA (1989) Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J Clin Invest 84:1849-1856
15. Lachowicz JE, Sibley DR (1997) Molecular characteristics of mammalian dopamine receptors. Pharmacol Toxicol 81:105-113
16. 2 dopamine receptor agonist quinpirole in rats. Fundam Clin Pharmacol 1:179-200
17. Li XX, Bek M, Asico LD, Yang Z, Grandy DK, Goldstein DS, Rubinstein M, Eisner GM, Jose PA (2001) Adrenergic and endothelin B receptor-dependent hypertension in dopamine receptor type-2 knockout mice. Hypertension 38:303-308
18. Lokhandwala MF, Steenberg ML (1984) Evaluation of the effects of SKF 82526 and LY 171555 on presynaptic (DA2) and post-synaptic (DA1) dopamine receptors in rat kidney. J Auton Pharmacol 4:273-277
19. 2 receptors mediate glomerular hyperfiltration due to amino acids. J Pharmacol Exp Ther 286:1248-1252
20. 3 receptor-induced renal changes in anesthetized rats. Pflügers Arch Eur J Physiol 437:R187
21. Missale C, Lombardi C, De Cotiis R, Memo M, Carruba MO, Spano PF (1989) Dopaminergic receptor mechanisms modulating the renin-angiotensin system and aldosterone secretion: an overview. J Cardiovasc Pharmacol 14:S29-S39
22. Mühlbauer B, Spöhr F, Schmidt R, Osswald H (1997) Role of renal nerves and endogenous dopamine in amino acid-induced glomerular hyperfiltration. Am J Physiol 273:F144-F149
23. 2 receptor agonist, in the anesthetized rat. J Pharmacol Exp Ther 239:426-432
24. 2 receptor agonist, in the conscious rat. J Pharmacol Exp Ther 236:735-742
25. 2-receptor activation inhibits noradrenaline release in human kidney slices. Kidney Int 43:197-204
26. 3 receptors in rat juxtaglomerular cells. Clin Exp Hypertens 19:93-105
27. 3H]quinpirole. Eur J Pharmacol 203:105-109
28. Siragy HM, Felder RA, Peach MJ, Carey RM (1992) Intrarenal DA2 dopamine receptor stimulation in the conscious dog. Am J Physiol 262:F932-F938
29. 3) as a target for neuroleptics. Nature 347:146-151
30. Stella A, Zanchetti A (1977) Effects of renal denervation on renin release in response to tilting and furosemide. Am J Physiol 232:H500-H507
31. Stella A, Calaresu F, Zanchetti A (1976) Neural factors contributing to renin release during reduction in renal perfusion pressure and blood flow in cats. Clin Sci Mol Med 51:453-461
32. 2 receptor agonist quinpirole on renal sympathetic nerve activity and renal norepinephrine spillover in anesthetized rabbits. J Pharmacol Exp Ther 263:806-815
33. Tsuruta K, Frey EA, Grewe CW, Cote TE, Eskay RL, Kebabian JW (1981) Evidence that LY-141865 specifically stimulates the D-2 dopamine receptor. Nature 292:463-465
34. Worth DP, Harvey JN, Brown J, Worral A, Lee MR (1986) Domperidone treatment in man inhibits the fall in plasma renin activity induced by intravenous gamma-L-glutamyl-L-dopa. Br J Clin Pharmacol 21:497-502